Related Experiment Video
Updated: Feb 27, 2026
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Current progress in host innate and adaptive immunity against hepatitis C virus infection
Jijing Shi1, Yuanyuan Li1, Wenxian Chang2
1Department of Infectious Diseases, Beijing 302 Hospital, Beijing, 100039, China.
Insights
Hepatitis C virus (HCV) infection impacts millions globally, leading to severe liver disease. Understanding host immunity is crucial for developing effective vaccines and treatments against this persistent viral threat.
Area of Science:
- Immunology
- Virology
- Hepatology
Background:
- Hepatitis C virus (HCV) affects over 170 million people worldwide, causing chronic hepatitis, liver cirrhosis, and liver cancer.
- Direct-acting antivirals (DAAs) have improved treatment but global control is hampered by cost, resistance, and lack of a vaccine.
- Host immune responses, particularly T-cell immunity, dictate whether HCV infection becomes acute or chronic.
Purpose of the Study:
- To review current advancements in Hepatitis C virus immunology.
- To deepen the understanding of the spectrum of HCV infection and immunity in humans.
- To highlight the importance of immunopathogenesis in developing strategies to eliminate HCV.
Main Methods:
- Literature review of recent studies on HCV immunology.
- Analysis of host immune responses in acute and chronic HCV infection.
- Synthesis of current knowledge on HCV pathogenesis and immune evasion.
Main Results:
- HCV infection outcome is significantly influenced by host-specific T-cell responses.
- DAAs, while effective, present challenges for widespread HCV control.
- A comprehensive understanding of HCV immunology is essential for future therapeutic and preventative strategies.
Conclusions:
- Further research into HCV immunology is vital for overcoming treatment limitations and developing a vaccine.
- Interpreting immunopathogenesis is key to designing effective global strategies for HCV elimination.
- Understanding the interplay between HCV and the human immune system is critical for managing and eradicating the virus.
Abstract:
Hepatitis C virus (HCV) infects more than 170 million people worldwide and is the main cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Although the newly developed direct-acting antivirals (DAAs) have transformed the treatment of HCV infection, controlling HCV infection on a global scale remains a challenge because of the high cost, low resistance barrier of DAAs and lack of HCV vaccine. The host immune responses associated with HCV infection, especially HCV-specific T cellular immunity, determine the outcome of HCV infection: either acute or chronic infection. It is important to fully interpret the immunopathogenesis of HCV infection and consequently to exploit effective strategies to eliminate HCV. Here, we review the current progress in HCV immunology, which will deepen our understanding of the spectrum of HCV infection and immunity in humans.
More Related Videos
Related Concept Videos
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:40Cell-mediated Immune Responses
01:21Introduction to Innate and Adaptive Immunity
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...